Merck & Company Inc - Depreciation and Amortization Expense

Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Depreciation-and-Amortization-Expense" stands at 4.57 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.

Merck & Company Inc's third quarter result of 1.15 Billion USD for the item "Depreciation and Amortization Expense" represents an increase of 3.13 percent compared to it's second quarter result.

Also, Merck & Company Inc's third quarter result of 1.15 Billion USD for the item "Depreciation and Amortization Expense" represents a decrease of -2.70 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Merck & Company Inc's third quarter result of 4.57 Billion USD for the item "Depreciation and Amortization Expense" represents a decrease of -0.7 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 7.10 percent compared to the value the year prior.
The 1 year change in percent is 7.10.
The 3 year change in percent is 18.61.
The 5 year change in percent is 24.94.
The 10 year change in percent is -28.48.

The Serie's long term average value is 5.05 Billion United States Dollars. It's latest available value, on 09/30/2025, is 9.57 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2021, to it's latest available value, on 09/30/2025, is +42.16%.
The Serie's change in percent from it's maximum value, on 12/31/2011, to it's latest available value, on 09/30/2025, is -38.48%.